Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes

A Calabrese, C von Arx, AA Tafuti, M Pensabene… - Cancer Treatment …, 2024 - Elsevier
The detection of germline pathogenic variants (gPVs) in BRCA1/2 and other breast cancer
(BC) genes is rising exponentially thanks to the advent of multi-gene panel testing. This …

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome

F Guijarro, M López-Guerra, J Morata… - Blood …, 2023 - ashpublications.org
Germ line predisposition in acute myeloid leukemia (AML) has gained attention in recent
years because of a nonnegligible frequency and an impact on management of patients and …

vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines

E Munté, L Feliubadaló, M Pineda, E Tornero… - …, 2023 - academic.oup.com
Motivation Germline variant classification allows accurate genetic diagnosis and risk
assessment. However, it is a tedious iterative process integrating information from several …

CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience

E Abdelghani, KM Schieffer, CE Cottrell, A Audino… - Cancers, 2023 - mdpi.com
Simple Summary Pediatric malignancies rarely occur, with 12,000–15,000 cases per year in
the United States. Approximately 10% of pediatric cancers are thought to be secondary to …

Characterization of a pleomorphic rhabdomyosarcoma cell line

S Stickler, C Lang, M Rieche, MT Eggerstorfer… - Scientific Reports, 2025 - nature.com
Pleomorphic rhabdomyosarcoma (PRMS) is an extremely rare soft tissue tumor with dismal
prognosis that has a higher incidence in adults compared to the other RMS subtypes. The …

CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma

Y Chen, Z Zhu, X Wu, H Li, W Guan, H Ren - Cell Death Discovery, 2024 - nature.com
Currently, there is still a lack of novel and effective drug targets to improve the prognosis of
hepatocellular carcinoma (HCC). Additionally, the role of CHEK2 in HCC has not been …

Comprehensive molecular profiling of colorectal cancer with situs inversus totalis by next-generation sequencing

H Li, L Gong, H Cheng, H Wang, X Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Colorectal cancer (CRC) is one of the most prevalent malignances worldwide.
However, CRC with situs inversus totalis (SCRC) is extremely rare, and molecular …

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing

F Lesueur, S Eon-Marchais, S Bonnet-Boissinot… - Cancers, 2021 - mdpi.com
Simple Summary TUMOSPEC was designed for estimating the risk of cancer for carriers of a
predicted pathogenic variant (PPV) in a gene usually tested in a hereditary breast and …

Frequency of pathogenic germline variants in pediatric medulloblastoma survivors

D Rees, DM Gianferante, J Kim, T Stavrou… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Background Medulloblastoma is the most common malignant brain tumor in children. Most
cases are sporadic, but well characterized germline alterations in APC, ELP1, GPR161 …

Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation

M Kartal-Kaess, A Karow, U Bacher… - Pediatric hematology …, 2024 - Taylor & Francis
Clonal hematopoiesis of indeterminate potential (CHIP) describes recurrent somatic gene
mutations in the blood of healthy individuals, associated with higher risk for hematological …